05/31/2023: Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
First US patients treated in international PULSAR IDE study to test safety and effectiveness of Globe System.
03/15/2023: Kardium announces first patients treated in PULSAR IDE study of Globe® Pulsed Field System
First patients treated in international, multicenter PULSAR study to test safety and effectiveness of Globe System.
11/08/2022: Successful First-in-Human Clinical Study of Kardium’s Next Generation Globe® Pulsed Field System
First-in-Human Trial of Kardium’s Next Generation Globe® Pulsed Field System
08/05/2021: Kardium selected as Medical/Digital Technology Company of the Year
Life Sciences BC has selected Kardium Inc. as the Medical/Digital Technology Company of the Year.
07/20/2021: More precise and effective: Innovative catheter technology in the cardiac catheterization laboratory
Cardiologists at the RHÖN-KLINIKUM Campus Bad Neustadt apply state-of-the-art single catheter complete solution for the treatment of atrial fibrillation for the first time.
01/25/2021: B.C. heart device firm Kardium founded by Creo executives raises $115-million from Fidelity, T. Rowe Price ahead of going public
Kardium's Globe Mapping and Ablation System is intended to disrupt a roughly $6-billion market for treating atrial fibrillation, which is expected to grow by 15 per cent a year as Baby Boomers age.
PV Isolation Using a Spherical Array PFA Catheter: Preclinical Assessment and Comparison to Radiofrequency Ablation (February 2023)
Golden Globes are Back for Pulsed Field Ablation (January 2023)
Globe Pulsed Field System for High-definition Mapping and Ablation for Atrial Fibrillation (December 2022)
Please call Kardium at 604.248.8891 or email email@example.com